Y
Yue Xu
Researcher at Stanford University
Publications - 16
Citations - 9978
Yue Xu is an academic researcher from Stanford University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 9, co-authored 12 publications receiving 5664 citations.
Papers
More filters
Journal ArticleDOI
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman,Chih Long Liu,Michael R. Green,Andrew J. Gentles,Weiguo Feng,Yue Xu,Chuong D. Hoang,Maximilian Diehn,Arash Ash Alizadeh +8 more
TL;DR: CIBERSORT outperformed other methods with respect to noise, unknown mixture content and closely related cell types when applied to enumeration of hematopoietic subsets in RNA mixtures from fresh, frozen and fixed tissues, including solid tumors.
Journal ArticleDOI
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles,Aaron M. Newman,Chih Long Liu,Scott V. Bratman,Scott V. Bratman,Weiguo Feng,Dongkyoon Kim,Viswam S. Nair,Yue Xu,Amanda Khuong,Chuong D. Hoang,Maximilian Diehn,Robert B. West,Sylvia K. Plevritis,Ash A. Alizadeh +14 more
TL;DR: A pan-cancer resource and meta-analysis of expression signatures from ∼18,000 human tumors with overall survival outcomes across 39 malignancies is presented and it is found that expression of favorably prognostic genes, including KLRB1 (encoding CD161), largely reflect tumor-associated leukocytes.
Journal ArticleDOI
Non–Small Cell Lung Cancer: Identifying Prognostic Imaging Biomarkers by Leveraging Public Gene Expression Microarray Data—Methods and Preliminary Results
Olivier Gevaert,Jiajing Xu,Chuong D. Hoang,Ann N. Leung,Yue Xu,Andrew Quon,Daniel L. Rubin,Sandy Napel,Sylvia K. Plevritis +8 more
TL;DR: This radiogenomics strategy for identifying imaging biomarkers may enable a more rapid evaluation of novel imaging modalities, thereby accelerating their translation to personalized medicine.
Journal ArticleDOI
A rare population of CD24+ITGB4+Notchhi cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal
Yanyan Zheng,Cecile de la Cruz,Leanne C. Sayles,Chris Alleyne-Chin,Chris Alleyne-Chin,Dedeepya Vaka,Tim D. Knaak,Marty Bigos,Yue Xu,Chuong D. Hoang,Joseph B. Shrager,Hans Joerg Fehling,Dorothy French,William F. Forrest,Zhaoshi Jiang,Richard A.D. Carano,Kai H. Barck,Erica L. Jackson,E. Alejandro Sweet-Cordero +18 more
TL;DR: The role of Notch3 in tumor propagation may provide a therapeutic target for NSCLC and the TPC population is enriched after chemotherapy, and the gene signature of mouse TPCs correlates with poor prognosis in humanNSCLC.
Journal ArticleDOI
A Meta-analysis of Lung Cancer Gene Expression Identifies PTK7 as a Survival Gene in Lung Adenocarcinoma
Ron Chen,Purvesh Khatri,Pawel K. Mazur,Melanie Polin,Yanyan Zheng,Dedeepya Vaka,Chuong D. Hoang,Joseph B. Shrager,Yue Xu,Silvestre Vicent,Atul J. Butte,E. Alejandro Sweet-Cordero +11 more
TL;DR: PTK7 is defined as a highly and specifically expressed gene in adenocarcinoma and a potential therapeutic target in this subset of non-small cell lung cancer (NSCLC); and RNA interference-mediated attenuation of PTK7 decreased cell viability and increased apoptosis in a subset of adenoplastoma cell lines.